Guru Ownership Trend
Guru Analysis for Rhythm Pharmaceuticals, Inc. (RYTM)
Rhythm Pharmaceuticals, Inc. (RYTM), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $88.5 M.
Top institutional holders include Steven Cohen and Stanley Druckenmiller.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $47.06 M net outflow during the quarter.
Recent activity highlights Stanley Druckenmiller who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 73.5%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Rhythm Pharmaceuticals, Inc. (RYTM)
Major holders include Steven Cohen ($45.99 M), Stanley Druckenmiller ($22.61 M), Renaissance Technologies (RenTech) ($7.58 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 764,719 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $47.06 M, with 2 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 4 managers trimmed their positions, while 0 fully exited RYTM. The total reported sell value was $69.74 M.
Yes, 1 managers opened new positions in RYTM, and 1 increased their existing holdings. The total reported buy value was $22.68 M.